Review
Published on 08 Aug 2022
The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.964934
- 6,777 views
- 32 citations
Type at least 3 characters
993 articles
Articles
Review
Published on 08 Aug 2022
Review: Precise sarcoma patient-derived orthotopic xenograft (PDOX) mouse models enable identification of novel effective combination therapies with the cyclin-dependent kinase inhibitor palbociclib: A strategy for clinical application
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.957844
- 3,212 views
- 8 citations
Editorial
Published on 05 Aug 2022
Editorial: Multi-target directed ligands for the treatment of cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.980141
- 1,817 views
- 9 citations
Original Research
Published on 05 Aug 2022
Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.954008
- 2,365 views
- 7 citations
Original Research
Published on 04 Aug 2022
Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.949868
- 2,256 views
- 4 citations
Correction
Published on 04 Aug 2022
Corrigendum: The risk of heart disease-related death among anaplastic astrocytoma patients after chemotherapy: A SEER population-based analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.995352
- 1,160 views
Original Research
Published on 04 Aug 2022
Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.972372
- 2,737 views
- 8 citations
Case Report
Published on 03 Aug 2022
Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.911202
- 3,496 views
- 5 citations
Brief Research Report
Published on 02 Aug 2022
Long-Read Sequencing Annotation of the Transcriptome in DNA-PK Inactivated Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.941638
- 2,664 views
- 1 citation
Original Research
Published on 01 Aug 2022
LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.937444
- 3,046 views
- 8 citations
Editorial
Published on 29 Jul 2022
Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.972718
- 1,117 views
Review
Published on 29 Jul 2022
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.960317
- 18,309 views
- 57 citations
Original Research
Published on 28 Jul 2022
The Role of NR4A1 in the Pathophysiology of Osteosarcoma: A Comprehensive Bioinformatics Analysis of the Single-Cell RNA Sequencing Dataset
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.879288
- 3,215 views
- 3 citations
Original Research
Published on 28 Jul 2022
Cell Death Triggers Induce MLKL Cleavage in Multiple Myeloma Cells, Which may Promote Cell Death
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.907036
- 3,207 views
- 3 citations
Original Research
Published on 26 Jul 2022
Paeoniflorin Inhibits EMT and Angiogenesis in Human Glioblastoma via K63-Linked C-Met Polyubiquitination-Dependent Autophagic Degradation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.785345
- 2,456 views
- 11 citations
Editorial
Published on 26 Jul 2022
Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.990144
- 1,020 views